119 related articles for article (PubMed ID: 21767187)
1. Spatiotemporal analysis of tumor uptake patterns in dynamic (18)FDG-PET and dynamic contrast enhanced CT.
Malinen E; Rødal J; Knudtsen IS; Søvik Å; Skogmo HK
Acta Oncol; 2011 Aug; 50(6):873-82. PubMed ID: 21767187
[TBL] [Abstract][Full Text] [Related]
2. Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors.
Abramyuk A; Wolf G; Shakirin G; Haberland U; Tokalov S; Koch A; Appold S; Zöphel K; Abolmaali N
Acta Radiol; 2010 Sep; 51(7):793-9. PubMed ID: 20583948
[TBL] [Abstract][Full Text] [Related]
3. F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET.
Zimny M; Kaiser HJ; Cremerius U; Sabri O; Schreckenberger M; Reinartz P; Büll U
Nuklearmedizin; 1999; 38(4):108-14. PubMed ID: 10392375
[TBL] [Abstract][Full Text] [Related]
4. Multimodality functional imaging of spontaneous canine tumors using 64Cu-ATSM and 18FDG PET/CT and dynamic contrast enhanced perfusion CT.
Hansen AE; Kristensen AT; Law I; McEvoy FJ; Kjær A; Engelholm SA
Radiother Oncol; 2012 Mar; 102(3):424-8. PubMed ID: 22119225
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
Vinod SK; Kumar S; Holloway LC; Shafiq J
J Med Imaging Radiat Oncol; 2010 Apr; 54(2):152-60. PubMed ID: 20518880
[TBL] [Abstract][Full Text] [Related]
7. Tumor volumes measured from static and dynamic 18F-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography scan: comparison of different methods using magnetic resonance imaging as the criterion standard.
Chen H; Jiang J; Gao J; Liu D; Axelsson J; Cui M; Gong NJ; Feng ST; Luo L; Huang B
J Comput Assist Tomogr; 2014; 38(2):209-15. PubMed ID: 24625616
[TBL] [Abstract][Full Text] [Related]
8. Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images.
Yu H; Caldwell C; Mah K; Poon I; Balogh J; MacKenzie R; Khaouam N; Tirona R
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):618-25. PubMed ID: 19683403
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of FDG single-photon emission computed tomography: Computed tomography in the diagnosis of head and neck cancers and study of its mechanism.
Li LF; Zhou SH; Zhao K; Wang SQ; Wu QL; Fan J; Cheng KJ; Ling L
Cancer Biother Radiopharm; 2008 Dec; 23(6):701-14. PubMed ID: 19317609
[TBL] [Abstract][Full Text] [Related]
10. Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients.
Dimitrakopoulou-Strauss A; Pan L; Strauss LG
Cancer Imaging; 2012 Sep; 12(1):283-9. PubMed ID: 23033440
[TBL] [Abstract][Full Text] [Related]
11. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
Schinagl DA; Vogel WV; Hoffmann AL; van Dalen JA; Oyen WJ; Kaanders JH
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1282-9. PubMed ID: 17967318
[TBL] [Abstract][Full Text] [Related]
12. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
Schwartz DL; Ford E; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellyn B; Mattes D; Meyer J; Phillips M; Leblanc M; Kinahan P; Krohn K; Eary J; Laramore GE
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):129-36. PubMed ID: 15629603
[TBL] [Abstract][Full Text] [Related]
13. Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers.
Henriques de Figueiredo B; Barret O; Demeaux H; Lagarde P; De-Mones-Del-Pujol E; Kantor G; de Clermont-Gallerande H; Richaud P; Fernandez P
Radiother Oncol; 2009 Dec; 93(3):479-82. PubMed ID: 19880207
[TBL] [Abstract][Full Text] [Related]
14. Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer.
Guido A; Fuccio L; Rombi B; Castellucci P; Cecconi A; Bunkheila F; Fuccio C; Spezi E; Angelini AL; Barbieri E
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):759-63. PubMed ID: 18834671
[TBL] [Abstract][Full Text] [Related]
15. Functional imaging to monitor vascular and metabolic response in canine head and neck tumors during fractionated radiotherapy.
Rødal J; Rusten E; Søvik Å; Skogmo HK; Malinen E
Acta Oncol; 2013 Oct; 52(7):1293-9. PubMed ID: 23879646
[TBL] [Abstract][Full Text] [Related]
16. Dynamic respiratory gated (18)FDG-PET of lung tumors - a feasibility study.
Knudtsen IS; Rødal J; Brustugun OT; Helland Å; Skretting A; Malinen E
Acta Oncol; 2011 Aug; 50(6):889-96. PubMed ID: 21767189
[TBL] [Abstract][Full Text] [Related]
17. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
[TBL] [Abstract][Full Text] [Related]
18. [18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer.
El-Bassiouni M; Ciernik IF; Davis JB; El-Attar I; Reiner B; Burger C; Goerres GW; Studer GM
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):286-93. PubMed ID: 17707283
[TBL] [Abstract][Full Text] [Related]
19. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer.
Paulino AC; Koshy M; Howell R; Schuster D; Davis LW
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1385-92. PubMed ID: 15817341
[TBL] [Abstract][Full Text] [Related]
20. PET/CT significance for planning radiotherapy of head and neck cancer.
Kolarova I; Vanasek J; Kandrnal V; Odrazka K; Dusek L; Chrobok V; Belohlavek O; Dolezel M; Petruzelka L; Michalek R; Jarkovsky J
Neoplasma; 2012; 59(5):536-40. PubMed ID: 22668019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]